FDA issued a Warning Letter to Stat Rx USA on 10/9/2012 as a result of this inspection.
483 Stat Rx USA Feb 2012

483 Stat Rx USA Feb 2012

$119 - Not in Stock

FDA investigators audited the Stat Rx USA - Gainesville, GA, United States facility and issued inspectional observations (via FDA 483) on 15 Feb 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 15 Feb 2012
  • Location: Gainesville, United States
  • FEI: 3005480647
Order